Protective immunity against Leishmania major induced by Leishmania tropica infection of BALB/c mice

Experimental Parasitology

Volumn 127, Issue 2, 2011, Pages 448-453

  Mahmoudzadeh Niknam, Hamid ^a   Kiaei, Simin Sadat ^a   Iravani, Davood ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

BALB c mice; CD4+ lymphocyte; CD4 lymphocyte; Delayed type hypersensitivity; Immunity; Interferon gamma; Interleukin 10; Leishmania major; Leishmania tropica

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; LEISHMANIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNITY; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION;

ANIMALS; CD4 LYMPHOCYTE COUNT; DISEASE MODELS, ANIMAL; FEMALE; HYPERSENSITIVITY, DELAYED; INTERFERON-GAMMA; INTERLEUKIN-10; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS;

ANIMALIA; LEISHMANIA MAJOR; LEISHMANIA TROPICA; MUS;

EID: 78751585436     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.10.008     Document Type: Article

References (35)

1. Anderson C.F., Lira R., Kamhawi S., Belkaid Y., Wynn T.A., Sacks D. IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. Journal of Immunology 2008, 180:4090-4097.
2. Bogdan C. Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cellular Microbiology 2008, 10:1221-1234.
3. Bottrel R.L., Dutra W.O., Martins F.A., Gontijo B., Carvalho E., Barral-Netto M., Barral A., Almeida R.P., Mayrink W., Locksley R., Gollob K.J. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infection and Immunity 2001, 69:3232-3239.
4. Chatelain R., Mauze S., Coffman R.L. Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunology 1999, 21:211-218.
5. Convit J., Ulrich M., Fernández C.T., Tapia F.J., Cáceres-Dittmar G., Castés M., Rondón A.J. The clinical and immunological spectrum of American cutaneous leishmaniasis. Transaction of the Royal Society of Tropical Medicine and Hygiene 1993, 87:444-448.
6. De Rossell R.A., Bray R.S., Alexander J. The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis. Parasite Immunology 1987, 9:105-115.
7. Desjeux P. Leishmaniasis. Nature Review of Microbiology 2004, 2:692.
8. Etges R., Müller I. Progressive disease or protective immunity to Leishmania major infection: the result of a network of stimulatory and inhibitory interactions. Journal of Molecular Medicine 1998, 76:372-390.
9. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. Journal of Experimental Medicine 1989, 170:2081-2095.
10. Kane M.M., Mosser D.M. The role of IL-10 in promoting disease progression in leishmaniasis. Journal of Immunology 2001, 166:1141-1147.
11. Kruisbeek, A.M., 2003. Isolation of mouse mononuclear cells. In: Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., Strober, W. (Eds.), Current Protocols in Immunology. John Wiley and Sons Inc., New York, UNIT 3.1.1-3.1.5.
12. Launois P., Maillard I., Pingel S., Swihart K.G., Xénarios I., Acha-Orbea H., Diggelmann H., Locksley R.M., MacDonald H.R., Louis J.A. IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 1997, 6:541-549.
13. Lira R., Mendez S., Carrera L., Jaffe C., Neva F., Sacks D. Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. Experimental Parasitology 1998, 89:331-342.
14. Magill A.J., Grögl M., Gasser R.A., Sun W., Oster C.N. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. New England Journal of Medicine 1993, 328:1383-1387.
15. Mahmoudzadeh-Niknam H. Induction of partial production against Leishmania major in BALB/c mice by Leishmania tropica. Scandinavian Journal of Laboratory Animal Sciences 2004, 31:201-207.
16. Mahmoudzadeh-Niknam H., Kiaei S.S., Iravani D. Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice. Korean Journal of Parasitology 2007, 45:103-109.
17. Mahmoudzadeh-Niknam H., Kiaei S.S., Iravani D. Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis. Korean Journal of Parasitology 2007, 45:247-253.
18. Milon G., Titus R.G., Cerottini J.C., Marchal G., Louis J.A. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice. Journal of Immunology 1986, 136:1467-1471.
19. Müller I., Kropf P., Etges R.J., Louis J.A. Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells. Infection and Immunity 1993, 61:3730-3738.
20. Noben-Trauth N., Lira R., Nagase H., Paul W.E., Sacks D.L. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. Journal of Immunology 2003, 170:5152-5158.
21. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annual Review of Immunology 1995, 13:151-177.
22. Reithinger R., Mohsen M., Aadil K., Sidiqi M., Erasmus P., Coleman P.G. Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. Emerging Infectious Diseases 2003, 9:727-729.
23. Roberts M.T. Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment. British Medical Bulletin 2006, 17:115-130.
24. Roberts M.T., Stober C.B., McKenzie A.N., Blackwell J.M. Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection. Infection and Immunity 2005, 73:7620-7628.
25. Ronet C., Hauyon-La Torre Y., Revaz-Breton M., Mastelic B., Tacchini-Cottier F., Louis J., Launois P. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. Journal of Immunology 2010, 184:886-894.
26. Sacks D., Anderson C. Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunological Review 2004, 201:225-238.
27. Sacks D., Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nature Review of Immunology 2002, 2:845-858.
28. Scharton-Kersten T., Scott P. The role of the innate immune response in Th1 cell development following Leishmania major infection. Journal of Leukocyte Biology 1995, 57:515-522.
29. Scott P. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. Journal of Immunology 1991, 147:3149-3155.
30. Solbach W., Lohoff M., Streck H., Rohwer P., Röllinghoff M. Kinetics of cell-mediated immunity developing during the course of Leishmania major infection in 'healer' and 'non-healer' mice. progressive impairment of response to and generation of interleukin-2. Immunology 1987, 62:485-492.
31. Stober C.B., Lange U.G., Roberts M.T., Alcami A., Blackwell J.M. IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. Journal of Immunology 2005, 175:2517-2524.
32. Tabbara K.S., Peters N.C., Afrin F., Mendez S., Bertholet S., Belkaid Y., Sacks D.L. Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection. Infection and Immunity 2005, 73:4714-4722.
33. Titus R.G., Lima G.C., Engers H.D., Louis J.A. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. Journal of Immunology 1984, 133:1594-1600.
34. Titus R.G., Ceredig R., Cerottini J.C., Louis J.A. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. Journal of Immunology 1985, 135:2108-2114.
35. Weiss E., Mamelak A.J., La Morgia S., Wang B., Feliciani C., Tulli A., Sauder D.N. The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases. Journal of American Academy of Dermatologists 2004, 50:657-675.